Genetic and Epigenetic Basis of Drug-Induced Liver Injury
Seminars in Liver Disease · 01.05.2023 · 43 (02) · 163-175
DOI: 10.1055/a-2097-0531 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Seminars in Liver Disease, erschienen am 01.05.2023. Verfasst von Snigdha Singh und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, All India Institute of Medical Sciences, Jodhpur, Rajasthan, India. Hauptthemen laut MEDLINE: Chemical and Drug Induced Liver Injury. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 105 Literaturangaben. Gefördert von: Indian Council of Medical Research.
Abstract (Originalsprache)
Drug-induced liver injury (DILI) is a rare but severe adverse drug reaction seen in pharmacotherapy and a major cause of postmarketing drug withdrawals. Advances in genome-wide studies indicate that genetic and epigenetic diversity can lead to inter-individual differences in drug response and toxicity. It is necessary to identify how the genetic variations, in the presence of environmental factors, can contribute to development and progression of DILI. Studies on microRNA, histone modification, DNA methylation, and single nucleotide polymorphisms related to DILI were retrieved from databases and were analyzed for the current research and updated to develop this narrative review. We have compiled some of the major genetic, epigenetic, and pharmacogenetic factors leading to DILI. Many validated genetic risk factors of DILI, such as variants of drug-metabolizing enzymes, HLA alleles, and some transporters were identified. In conclusion, these studies provide useful information in risk alleles identification and on implementation of personalized medicine.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Biochemistry, All India Institute of Medical Sciences, Jodhpur, Rajasthan, India.
- Department of Pharmacy Practice, Manipal College of Pharmaceutical Sciences, Manipal, Karnataka, India.
Förderung
- Indian Council of Medical Research
Zitieren
APA
Singh, S., Kumar, P. V. S. N. K., Kumar, J. P., Tomo, S., Yadav, D., Sharma, P., Rao, M., & Banerjee, M. (2023). Genetic and Epigenetic Basis of Drug-Induced Liver Injury. Seminars in Liver Disease, 43(02), 163-175. https://doi.org/10.1055/a-2097-0531
Vancouver
Singh S, Kumar PVSNK, Kumar JP, Tomo S, Yadav D, Sharma P, et al. Genetic and Epigenetic Basis of Drug-Induced Liver Injury. Seminars in Liver Disease. 2023;43(02):163-175. doi:10.1055/a-2097-0531
BibTeX
@article{Singh2023,
author = {Singh, Snigdha and Kumar, P V S N Kiran and Kumar, J Pradeep and Tomo, Sojit and Yadav, Dharamveer and Sharma, Praveen and Rao, Mahadev and Banerjee, Mithu},
title = {Genetic and Epigenetic Basis of Drug-Induced Liver Injury},
journal = {Seminars in Liver Disease},
year = {2023},
volume = {43},
number = {02},
pages = {163--175},
doi = {10.1055/a-2097-0531}
}
EUVIMED